Pomerantz Law Firm Investigates Potential Securities Fraud at Disc Medicine, Inc.
Pomerantz LLP is investigating potential securities fraud at Disc Medicine, Inc. (IRON), following significant stock price declines linked to FDA concerns over its drug bitopertin. The firm is seeking to represent investors affected by alleged unlawful business practices.
Tickers: $IRON
Topics: class action FDA review pharmaceuticals securities fraud stock price drop